PYPD Stock Analysis: Buy, Sell, or Hold?
PYPD - PolyPid Ltd. Ordinary Shares
$4.58
-0.13 (-2.76%)
▼
5d:
-4.18%
30d:
+4.57%
90d:
+20.53%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
8d
Get Alerted When PYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PYPD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PYPD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: PYPD shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PYPD is currently trading at $4.58, which is considered fair relative to its 30-day fair value range of $4.31 to $4.72.
Technical Outlook: Technically, PYPD is in a strong uptrend. Immediate support is located at $4.25, while resistance sits at $5.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.25 (+167.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PYPD is in a strong uptrend. Immediate support is located at $4.25, while resistance sits at $5.05.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.25 (+167.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$4.31 -
$4.72
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 167.5% below Wall St target ($12.25)
Fair Price Analysis
30-Day Fair Range
$4.31 -
$4.72
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.25
Resistance Level
$5.05
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.61
Wall Street Target
$12.25
(+167.5%)
Last updated: February 01, 2026 9:37 PM ET
Data refreshes hourly during market hours. Next update: 10:37 PM
Data refreshes hourly during market hours. Next update: 10:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
